ACE and neoplasm: Future perspectives will involve tumor-targeted fluorescence imaging by using a fluorescent dye coupled with a specific antibody targeting a tumoral antigen (e.g., ACE) in order to identify the tumor limits and the metastatic disease along the lymph node basin [72,73].